The Study of Knowledge and Ability of Registered Nurses in vaccine preparation and vaccination according to the guidelines and satisfaction of Registered Nurses from use of guidelines for the management of COVID-19 ChAdox1-n CoV vaccines (AstraZeneca)
Keywords:
knowledge and ability, Guidelines, satisfactionAbstract
This research is study to knowledge and ability of registered nurses in vaccine preparation and vaccination according to the guidelines for the management of COVID-19 ChAdox1-n CoV vaccines (AstraZeneca) and study to satisfaction of registered nurses from using of the guidelines for the management of COVID-19 ChAdox1-n CoV vaccines (AstraZeneca). The sample group were volunteer registered nurses vaccinate Number 30 People. The tools used in the research are 1) guidelines for the management of COVID-19 ChAdox1-n CoV vaccines (AstraZeneca) 2) General information recording form 3) Knowledge test before and after 4) Compliance assessment questionnaire and 5) satisfaction assessment questionnaire for implementing the guidelines for the management of COVID-19 ChAdox1-n CoV vaccines (AstraZeneca). Data are analyzed with basic statistics: frequency, percentage, deviation. standard and t-test.
The results showed that registered nurses had knowledge scores in preparation and vaccination according to the guidelines for the management of COVID-19 ChAdox1-n CoV vaccines (AstraZeneca) before and after educating on average 8.60 ± 1.10 and 9.67 ± 1.10. 0.55 knowledge scores on preparation and vaccination after educating more than before educating mean 1.07 points. (95%CI: 0.68,1.46) statistically significant (p-value < 0.001). They are satisfied with the use of the guidelines for the management of COVID-19 ChAdox1-n CoV vaccines (AstraZeneca) at the highest level.
References
AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine National Protocol Astra Zeneca COVID-19 Vaccine; 2021.
Australian Technical Advisory Group for Immunisations. AstraZeneca COVID-19 Vaccine Multidose Vial Preparation. AstraZeneca COVID-19 Vaccine; 2021.
NHS Greater Glasgow & Clyde Patient Group Direction (PGD) for Healthcare Professionals. AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]). AstraZeneca COVID-19 Vaccine; 2021.
Pfizer-BioNTech COVID-19 Vaccine and LOW DEAD-VOLUME (LDV) SYRINGES AND/OR NEEDLES; 2021.
Information about LOW DEAD-VOLUME SYRINGES AND/OR NEEDLES for Pfizer-BioNTech COVID-19 Vaccine; 2021.
Rigoni M, Torri E, Nollo G, Donne LD, Rizzardo S, Lenzi L, et al. “Long COVID” results after hospitalization for SARS-CoV-2 infection. Scientific Reports. 2022;12(1):9581.
Verma P, Chaudhary S, Kaur S, Midha T, Martolia DS. Impact of co-morbidities in COVID -19 infected patients. Indian Journal of Community Health. 2022 ;34(1):26-9.
Kouhpayeh H. Clinical features predicting COVID-19 mortality risk. European Journal Translational Myology. 2022;32(2).
Phankavong P, Prueksaanantakal N, Benjakul N, Manomaipiboon A. Effectiveness of the air-filled technique to reduce the dead space in syringes and needles during ChAdox1- n CoV vaccine administration. 2022. preprint in medRxiv. doi: https://doi.org/10.1101/ 2022.04.28.22274427
Manomaipiboon A, Phumisantiphong U, Maneerit J, Chalearmchai Y, Jirawathin W, Prajongsai A, et al. Immunogenicity of the ChAdOx1 n CoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis. Vaccine. 2022;40(4):587-93.
Nursing Department of Faculty of Medicine Vajira Hospital. Navamindradhiraj University. Guidelines for administartion COVID-19 vaccine ChAdox1- n CoV (AstraZeneca). 2021; WI- NUR 01-NN-024. (in Thai)
Di Giuseppe G, Pelullo CP, Lanzano R, Napolitano F, Pavia M. Knowledge, attitudes, and behavior of incarcerated people regarding COVID-19 and related vaccination: a survey in Italy. Scientific Reports. 2022;12(1):960.
Manomaipiboon A, Trakarnvanich T, Phumisantiphong U, Maneerit G, Dachavong P, Chalermchai Y, et al. Immunogenicity after the first dose of ChAdox1 nCoV-19 Vaccine (AstraZeneca) with twelve doses per vial technique: an interim analysis; 2021. (in Thai)
Phumisantiphong U, Chunhakan S, Manomaipiboon A, Maneerit J, Dechanuwong P, Trakarnvanich T, et al. Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford-Astra Zeneca vaccines in healthcare workers in Thailand. Vaccine X. 2023;13:100277.
Trakarnvanich T, Ngamvichchukorn T, Phumisantiphong U, Pholtawornkulchai K, Phochanasomboon K, Manomaipiboon A. Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant. Vaccine. 2022;40(45): 6499-511.
Manomaipiboon A, Pholtawornkulchai K, Poopipatpab S, Suraamornkul S, Maneerit J, Ruksakul W, et al. Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial. Trials. 2022;23(1):714.
Khan MI, Ikram A, Hamza HB. Vaccine manufacturing capacity in low-and middle-income countries. Bull World Health Organ. 2021;99(7):479-A.
Fu Y, Zhao J, Wei X, Han P, Yang L, Ren T, et al. Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies. Front Public Health. 2022;10:917732.
Khongsaman P, Jinda J. The Development of Clinacal Nursing Practice Guideline for the Patients under Investigation and/ or Infected with Coronavirus 2019 (COVID-19) in Emergency Department. Journal of The Thai Army Nurses. 2022;23(1) : 159-68.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of The Royal Thai Army Nurses
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความหรือข้อคิดเห็นใดใดที่ปรากฏในวารสารพยาบาลทหารบกเป็นวรรณกรรมของผู้เขียน ซึ่งบรรณาธิการหรือสมาคมพยาบาลทหารบก ไม่จำเป็นต้องเห็นด้วย
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารพยาบาลทหารบก
The ideas and opinions expressed in the Journal of The Royal Thai Army Nurses are those of the authors and not necessarily those
of the editor or Royal Thai Army Nurses Association.
